Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Akari Therapeutics PLC

Current price
1.17 USD +0.056 USD (+5.06%)
Last closed 1.21 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 9 746 151 USD
Yield for 12 month +455.33 %
21.11.2021 - 28.11.2021

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid, as well as pre-clinical program developing long-acting PASylated-nomacopan for treatment of geographic atrophy secondary to dry age-related macular degeneration. The company is based in London, the United Kingdom. Address: 75/76 Wimpole Street, London, United Kingdom, W1G 9RT

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

80 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-4 000 USD

Last Year

-3 708 USD

Current Quarter

Last Quarter

Key Figures AKTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -16 802 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -115.51 %
PEG Ratio
Return On Equity TTM -1281.43 %
Wall Street Target Price 80 USD
Revenue TTM
Book Value -0.035 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -2.04 USD
Diluted Eps TTM -2.04 USD
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics AKTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AKTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 17.08.2023
Dividend Date

Stock Valuation AKTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.3418
Price Book MRQ 3.0692

Financials AKTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AKTX

For 52 weeks

1.1 USD 5.5 USD
50 Day MA 2.05 USD
Shares Short Prior Month 5 949
200 Day MA 3.11 USD
Short Ratio 0.76
Shares Short 10 516
Short Percent 0.19 %

Dynamics of changes in the value of assets




399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds



207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics



2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics